Dr. Philip Blanco Antiporta, MD

Dr. Antiporta practices at Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources.

Dr. Antiporta's NPI, 1104139732, was assigned on July 25, 2010. Dr. Antiporta graduated from University of Santo Tomas in 2007. Dr. Antiporta's Texas license number on file is R8147.

Dr. Antiporta's primary practice is Texas Health Fort Worth, at 1301 Pennsylvania Avenue, Fort Worth, TX 76104 in Tarrant County. The practice phone is (817) 250-2100.

Dr. Antiporta's primary practice is Texas Health Fort Worth in Fort Worth, Texas, part of Texas Health Resources. Dr. Antiporta is also affiliated with Baylor Scott & White All Saints Medical Center - Fort Worth. The medical group on file is Infectious Disease Doctors, PA. Dmand AI also links Dr. Antiporta to 1 more hospital, 1 group practice or clinic and 1 home health agency, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Antiporta practices, 5 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Antiporta's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Antiporta is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Antiporta's licenses on file in 3 states: Texas, Illinois and Michigan.

Dmand AI lists acute skin infection, facial skin infection, hiv/aids, immune deficiency disease, joint or bone infection, pneumonia and UTI among the conditions Dr. Antiporta treats.

CMS data shows 1,266 Medicare services from Dr. Antiporta across 11 procedure codes in 2024, for 219 Medicare patients. Medicare paid $104,712 for them.

CMS counts 219 Medicare patients who saw Dr. Antiporta in 2024. The largest group is 65 to 74, with 87 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 3.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Antiporta's median patient age at 69, with 43% women.

In 2024, Dr. Antiporta wrote 1,139 Medicare Part D claims for 155 patients. 84% of them were for generic drugs. CMS names the drug for 1,000 of them, across 25 drugs with 11 or more claims each, at $449,858 in total drug cost. In 2023, CMS named 527 claims across 14 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 22 out of 100 for Dr. Antiporta for performance year 2024, reported individually. Dr. Antiporta accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 6 papers to Dr. Antiporta, published from 2015 to 2022. 2022 was the busiest year, with 2. The most frequent topics are Antifungal Agents. Dr. Antiporta has published most often in Transpl Infect Dis. Dr. Antiporta's most frequent co-authors are Zainab Abbas, Shira R. Abeles, MD and Sara Hurtado Bares, MD.

Dmand AI lists 2 awards for Dr. Antiporta, most recently Third Year Resident of the Year in 2013. Dr. Antiporta serves on Infection Control and Prevention - Roseland Community Hospital.

Dr. Antiporta graduated from University of Santo Tomas in 2007.

Dr. Antiporta is in network with 21 carriers, including Blue Cross Blue Shield of Michigan, Elevance and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.